NFAM:CA:TSX-NBI Canadian Family Business (CAD)

COMMON STOCK | |

Last Closing

CAD 28.94

Change

-0.37 (-1.26)%

Market Cap

CAD 3.88M

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
RY-PZ:CA Royal Bank of Canada Pref Z

N/A

CAD 216.03B
TD-PFB:CA Toronto Dominion Bank Pref B

N/A

CAD 194.95B
TD-PFD:CA Toronto Dominion Bank Pref D

+0.58 (+2.60%)

CAD 158.63B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.16 (+0.65%)

CAD 158.29B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

+0.04 (+0.16%)

CAD 142.22B
ENB-PFV:CA Enbridge Inc Pref 5

+0.08 (+0.38%)

CAD 107.80B
ENB-PFA:CA Enbridge Inc Pref 9

+0.13 (+0.77%)

CAD 102.00B
ENB-PFC:CA Enbridge Inc Pref 11

+0.24 (+1.49%)

CAD 97.64B
ENB-PFG:CA Enbridge Inc Pref 15

+0.49 (+3.15%)

CAD 93.86B
ENB-PFU:CA Enbridge Inc Pref L

-0.09 (-0.44%)

CAD 78.74B

ETFs Containing NFAM:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.46% N/A N/A 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.46% N/A N/A 66% D+
Trailing 12 Months  
Capital Gain 11.31% N/A N/A 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.31% N/A N/A 60% D-
Trailing 5 Years  
Capital Gain 39.47% N/A N/A 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.47% N/A N/A 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 9.98% N/A N/A 75% C
Dividend Return 11.21% N/A N/A 73% C
Total Return 1.23% N/A N/A 40% F
Risk Return Profile  
Volatility (Standard Deviation) 21.90% N/A N/A 41% F
Risk Adjusted Return 51.20% N/A N/A 74% C
Market Capitalization 3.88M N/A N/A 4% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike